ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 63 filers reported holding ENTELLUS MED INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $192,000 | -87.2% | 13,900 | -82.4% | 0.00% | -100.0% |
| Q4 2016 | $1,495,000 | +5.3% | 78,800 | +23.1% | 0.00% | -33.3% |
| Q3 2016 | $1,420,000 | +147.4% | 64,000 | +103.8% | 0.00% | +200.0% |
| Q2 2016 | $574,000 | +177.3% | 31,400 | +175.4% | 0.00% | – |
| Q1 2016 | $207,000 | – | 11,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $54,577,000 | 41.39% |
| Discovery Group I, LLC | 2,089,974 | $38,581,000 | 14.72% |
| Essex Woodlands Management, Inc. | 3,231,656 | $59,656,000 | 10.58% |
| Archon Capital Management LLC | 550,224 | $10,157,000 | 5.46% |
| First Light Asset Management, LLC | 632,737 | $11,680,000 | 3.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $6,303,000 | 2.45% |
| Ghost Tree Capital, LLC | 561,510 | $10,365,000 | 2.20% |
| Aisling Capital LLC | 528,655 | $9,759,000 | 1.60% |
| Cypress Capital Management LLC (WY) | 66,965 | $1,236,000 | 1.46% |
| Endurant Capital Management LP | 208,771 | $3,854,000 | 1.17% |